Author

VINOD S. BURADE

Observed names: Burade, Vinod, VINOD BURADE, Vinod Burade

OpenAlex ID: A5000612159

766-P: Safety and Tolerability of Once-Weekly GL0034 (Utreglutide) in Healthy Individuals—A Multiple Ascending Dose Study

2023 · RAJAMANNAR THENNATI, VINOD S. BURADE, et al. · Diabetes · 2

759-P: Effects of Once-Weekly Utreglutide (GL0034) in Individuals with Overweight and Obesity on Lipid Metabolism—A 10-Week Exploratory Proof-of-Concept Study

2025 · RAJAMANNAR THENNATI, VINOD S. BURADE, et al. · Diabetes · 1

765-P: A Single Ascending Dose Study of the Novel GLP-1 Receptor Agonist GL0034 (Utreglutide) in Obese Individuals without Diabetes

2023 · RAJAMANNAR THENNATI, VINOD S. BURADE, et al. · Diabetes · 1

Insulinomimetic Effects of Tyrosine Kinase Inhibitors via PPAR-γ/Akt-Mediated β-Cell Preservation in Type 2 Diabetes Mellitus

2026 · Ekta Radadiya, Vinod Burade, et al. · Research Square

2833-LB: Utreglutide (GL0034) Shows Comparable Tolerability and Efficacy with Different Dose Escalation Regimens in Overweight and Obese Adults with Type 2 Diabetes (T2DM)

2026 · RAJAMANNAR THENNATI, GRIT ANDERSEN, et al. · Diabetes

1700-P: Durable Cardiometabolic Effects of Utreglutide in Metabolic Dysfunction–Associated Steatotic Liver Disease Patients with Nondiabetic and Prediabetic Status

2026 · RAJAMANNAR THENNATI, VINOD BURADE, et al. · Diabetes

FRI-199 Effect of utreglutide on cardio-metabolic and non-invasive fibrotic biomarkers in participants with metabolic-dysfunction associated steatotic liver disease

2026 · Rajamannar Thennati, Vinod Burade, et al. · Journal of Hepatology

Author response for "Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001"

2025 · Manchanda, Yusman, Jones, Ben, et al. · Publons reviews and discussion

116-OR: GL0034 (Utreglutide), a Novel GLP-1RA, Increases Liver FGF-21 and Demonstrates Significant Efficacy on Weight Loss, HbA1c, and Triglycerides in db/db Mice

2024 · RAJAMANNAR THENNATI, VINOD S. BURADE, et al. · Diabetes

121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study

2024 · RAJAMANNAR THENNATI, VINOD S. BURADE, et al. · Diabetes

744-P: Effects of a Novel Long-Acting GIP/GLP-1/Glucagon Trireceptor Agonist, HISHS-3001, on HbA1c, Body Weight, and Lipid Metabolism

2022 · VINOD S. BURADE, ADOLFO GARCIA-OCANA, et al. · Diabetes

Works count: 12

Citation count: 4

H-index: 1

I10-index: